{"id":"W4317877703","doi":"10.1200/jco.2023.41.4_suppl.tps260","title":"NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; Natera","keywords":"Medicine; Irinotecan; Internal medicine; Oxaliplatin; Oncology; Cohort; Regimen; Randomized controlled trial; Clinical endpoint; Colorectal cancer; Prospective cohort study; Chemotherapy; Stage (stratigraphy); Adjuvant; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004412784,0.0003817786,0.0003795634,0.0002434365,0.00008926553,0.0002388795,0.0004072096,0.0004801803,0.01068519],"category_scores_gemma":[0.0005214792,0.0001131327,0.0002727747,0.0002824312,0.0001985424,0.0001696605,0.0002823023,0.0009115362,0.002384651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004587124,"about_ca_system_score_gemma":0.0007208005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007321848,"about_ca_topic_score_gemma":0.002823924,"domain_scores_codex":[0.9998676,0.0000623349,0.000006851953,0.00002388774,0.0000227297,0.00001668112],"domain_scores_gemma":[0.9998009,0.00003309152,0.00005096897,0.00002144803,0.00001728032,0.00007634541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08645888,0.00308122,0.0152484,0.001795441,0.0002983881,0.0005828707,0.00006356952,0.002221031,0.0343405,0.001591254,0.05807679,0.7962418],"study_design_scores_gemma":[0.1473472,0.2399993,0.1538177,0.001706053,0.001594154,0.00758663,0.00009390682,0.008168097,0.02777978,0.002885872,0.4088924,0.0001290163],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8193048,0.04389985,0.005420208,0.007722175,0.001329731,0.004443947,0.01163556,0.002266995,0.1039767],"genre_scores_gemma":[0.914492,0.01215822,0.01456114,0.004026396,0.0003809583,0.002605738,0.01346465,0.0002239842,0.03808682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01068519,"threshold_uncertainty_score":0.0357455,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1155872252702977,"score_gpt":0.4654234957018605,"score_spread":0.3498362704315627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}